OncoLink Cancer Treatment and Resources
Link to OncoLink

Bone growth factor inhibits proliferation of multiple myeloma cells

Ultima Vez Modificado: 1 de noviembre del 2001

Last Updated: 2001-02-07 17:30:40 EST (Reuters Health) - Bone morphogenetic protein (BMP)-4, a member of the transforming growth factor-beta superfamily, inhibits proliferation of multiple myeloma cells and cell lines, according to a report in the January 15th issue of Blood.

In their introduction, the authors explain that bone morphogenetic proteins regulate growth, differentiation, and apoptosis in various cell lines and have been shown to modulate growth and differentiation of hematopoietic stem cells in adult mice. Also, interleukin (IL)-6 induces proliferation and prevents apoptosis of multiple myeloma cells.

Dr. Oyvind Hjertner and colleagues from the Norwegian University of Science and Technology in Trondheim tested the effects of BMP-4 on freshly isolated multiple myeloma (MM) cells and on MM cell cultures and evaluated its influence on IL-6-induced changes in MM cell cultures.

BMP-4 reduced DNA synthesis in IL-6-dependent MM cell lines, but not in IL-6-independent MM cell lines, the researchers report. BMP-4 also induced apoptosis in two IL-6-dependent cell lines. They also found that BMP-4 counteracted the upregulation of Stat3 protein by IL-6 (a possible mechanism of IL-6's anti-apoptotic effects) in the two cell lines tested.

Four of 13 freshly isolated, primary myeloma cell cultures showed >10% loss of viability in response to BMP-4 treatment, the investigators say, and 3 of the 13 cell cultures proliferated in response to IL-6. BMP-4 at least partly counteracted the effects of IL-6 in all three of these latter cultures.

"Our data suggest that treatment with BMP-4 or its analogues should be tried in animal models and possibly in patients with MM," Dr. Hjertner and colleagues conclude. "The activation of BMP receptors may reduce tumor burden and ameliorate bone disease, and it represents a new target for the treatment of this disease."

Reference

  • Blood 2001;97:516-522.

  • OncoLink I wish u knew...

    Learning as much as you can about your cancer diagnosis gives you the tools you need to make treatment decisions. Read more.

    Cancer Types
    Bone Cancer
    Brain Tumors
    Breast Cancer
    Carcinoid Tumors
    Endocrine System Cancers
    Gastrointestinal Cancers
    Gynecologic Cancers
    Head and Neck Cancers
    Leukemia
    Lung Cancers
    Lymphomas
    Myelomas
    Pediatric Cancers
    Penile Cancer
    Prostate Cancer
    Sarcomas
    Skin Cancers
    Testicular Cancer
    Thyroid Cancer
    Urinary Tract Cancers
    OncoLink Vet

    Cancer Treatment
    Biologic Therapy
    Bone Marrow Transplants
    Chemotherapy

    Clinical Trials
    Complementary Medicine
    Gene Therapy
    General Treatment Concerns
    Hormone Therapy
    PDT Center
    Proton Therapy
    Radiation Oncology
    Surgical Oncology
    Targeted Therapies
    Vaccine Therapies

    Cancer Support
    Caregivers
    Hospice Care and Bereavement
    Nutrition and Cancer
    Sexuality & Fertility
    Side Effects
    Support
    Survivorship
    Exercise and Cancer

    Cancer Resources
    Cancer News
    OncoLink University
    Nurses' Notes
    Conferences
    Newly Diagnosed Patients
    Causes and Prevention
    Legal and Financial Information for Patients
    LGBT Resources
    NCI Resources
    Global Resources
    Cancer Resource List
    Resources for Young Adults

    OncoLink Media Library
    OncoLink TV
    Book, Music and Video Reviews


    Ask the Experts
    Brown Bag Chat
    Tracy's Corner

    About OncoLink
    About OncoLink
    Giving to OncoLink
    Contact Information
    Usage Policy
    Editorial Board
    How to Partner with OncoLink
    Link to OncoLink
    Mission Statement

    OncoLink Cancer Resources RSS What's New RSS